Porphyria cutanea tarda associated with an acute gastrointestinal bleed: The roles of supplemental iron and blood transfusion

Cutis

Volumn 68, Issue 2, 2001, Pages 147-150

  Shehan, James M ^a  

^a CREIGHTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE DISEASE; AGED; ARTICLE; BLOOD TRANSFUSION; CASE REPORT; DUODENUM ULCER; FEMALE; FOLLOW UP; HUMAN; IRON INTAKE; METHODOLOGY; MULTIMODALITY CANCER THERAPY; PEPTIC ULCER BLEEDING; PORPHYRIA CUTANEA TARDA; RISK ASSESSMENT;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; BLOOD TRANSFUSION; COMBINED MODALITY THERAPY; DUODENAL ULCER; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRON, DIETARY; PEPTIC ULCER HEMORRHAGE; PORPHYRIA CUTANEA TARDA; RISK ASSESSMENT;

EID: 0035430432     PISSN: 00114162     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (5)

1. Waldenstrom J. Studien über porphyrie. Acta Med Scand. 1937;82(suppl):1.
2. Sweeney GD. Porphyria cutanea tarda, or the uroporphyrinogen decarboxylase deficiency diseases. Clin Biochem. 1986;19:3-15.
3. Bottomley SS. Secondary iron overload disorders. Semin Hematol 1998;35:77-86.
4. Elder GH. Porphyria cutanea tarda. Semin Liver Dis. 1998:18:67-75.
5. Anderson KE, Goeger DE, Carson RW, et al. Erythropoietin for the treatment of porphyria cutanea tarda in a patient on long-term hemodialysis. N Engi J Med. 1990;322:315-317.